tiprankstipranks
Advertisement
Advertisement

JNJ Stock Latest News

3 Vanguard ETFs Are Beating the S&P 500 in 2026 – Should You Buy?
Market News3 Vanguard ETFs Are Beating the S&P 500 in 2026 – Should You Buy?
2d ago
PG
COP
White House says imposing tariffs on patented pharmaceutical products
PremiumThe Fly
White House says imposing tariffs on patented pharmaceutical products
3d ago
AZN
BMY
Trump Trade: President says Iran war will still take weeks
PremiumThe Fly
Trump Trade: President says Iran war will still take weeks
3d ago
AA
MT
Trump administration readying new pharmaceutical tariffs, FT reports
PremiumThe Fly
Trump administration readying new pharmaceutical tariffs, FT reports
3d ago
AZN
BMY
Best ETFs to Invest In, According to AI Analyst, 4/1/2026
PremiumMarket News
Best ETFs to Invest In, According to AI Analyst, 4/1/2026
4d ago
MU
JNJ
Trump Trade: U.S. not pulling assets from Strait of Hormuz yet
PremiumThe FlyTrump Trade: U.S. not pulling assets from Strait of Hormuz yet
5d ago
AZN
BMY
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
Premium
The Fly
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
5d ago
AZN
BMY
3 Best ETFs to Invest In, According to AI Analyst, 03/30/2026
Premium
Market News
3 Best ETFs to Invest In, According to AI Analyst, 03/30/2026
6d ago
MU
JNJ
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
PremiumThe Fly
Alumis shares should trade higher on ‘major success’ at AAD, says Ramond James
6d ago
JNJ
TAK
Alumis price target raised to $55 from $50 at Oppenheimer
PremiumThe Fly
Alumis price target raised to $55 from $50 at Oppenheimer
6d ago
JNJ
TAK
Nanobiotix presents first data from CONVERGE study
PremiumThe Fly
Nanobiotix presents first data from CONVERGE study
6d ago
JNJ
NBTX
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
PremiumThe Fly
Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804
6d ago
JNJ
RPRX
J&J announces new long-term 52-week data from Phase 3 Iconic-Advance 1, 2
PremiumThe FlyJ&J announces new long-term 52-week data from Phase 3 Iconic-Advance 1, 2
7d ago
JNJ
Best ETFs to Invest In, According to AI Analyst, 3/26/2026
Premium
Market News
Best ETFs to Invest In, According to AI Analyst, 3/26/2026
10d ago
MU
AMX
Best ETFs to Invest In, According to AI Analyst, 3/25/2026
Premium
Market News
Best ETFs to Invest In, According to AI Analyst, 3/25/2026
11d ago
KO
HDV
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
PremiumMarket News
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
17d ago
BSX
IHE
Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts
PremiumAnalysts
Johnson & Johnson Stock Forecast: Trending Bullish Among Analysts
17d ago
JNJ
Early Icotyde Approval Strengthens Johnson & Johnson’s Immunology Growth Outlook and Multi‑Billion‑Dollar Potential
PremiumRatings
Early Icotyde Approval Strengthens Johnson & Johnson’s Immunology Growth Outlook and Multi‑Billion‑Dollar Potential
17d ago
JNJ
Johnson & Johnson price target raised to $234 from $217 at Barclays
PremiumThe Fly
Johnson & Johnson price target raised to $234 from $217 at Barclays
17d ago
JNJ
Icotyde label upside surprise for Protagonist, says H.C. Wainwright
PremiumThe FlyIcotyde label upside surprise for Protagonist, says H.C. Wainwright
18d ago
JNJ
PTGX
Trump Trade: President issues short-term waiver of Jones Act
Premium
The Fly
Trump Trade: President issues short-term waiver of Jones Act
18d ago
AZN
BMY
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
Premium
The Fly
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
18d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >